Teva Pharmaceutical Industries Limited

TEVA.TA·Tel Aviv·Healthcare
Compare
13,210.00+30.00 (+0.23%)today
As of Nov 5, 2:20 PM IST · May be delayed up to 15 min · ILA

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close13,180.00
Open13,130.00
Day range13,130.0013,340.00
52-week range7,721.0013,570.00
Off day high−0.97%
Off 52-week high−2.65%
Volume890.27K
Avg. volume (3M)1.16M
Market cap154.07B
EPS (TTM)1.33
Forward P/E47.69
P/E ratio (TTM)99.32
Dividend yield—
Beta (5Y)0.82
Shares outstanding1.17B
Short interest—
Earnings dateNov 3, 2026 (est.)
Analyst target—
Profit margin4.08%

Against its peers

Compare in full ›
TEVA.TA JUBLPHARMA.BO TAK EMCURE.BO 1795.TW IOLCP.NS
Market cap 154.07B 150.00B 67.28B 424.98B 44.76B 55.50B
P/E (TTM) 99.3 42.7 300.9 38.9 11.8 27.3
Forward P/E 47.7 18.7 39.7 27.9 7.1 17.5
Price/book 19.3 2.1 1.4 8.0 1.9 2.9
Dividend yield — 0.53% 2.93% 0.17% 1.61% 0.54%
1-year change +66.60% −19.11% +54.40% +59.82% −42.88% +102.86%
Today +0.23% +0.79% +1.49% +3.02% +5.66% +2.89%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Latest news

All TEVA.TA news ›
Seeking Alpha·Positive

Teva: I Still See Upside After A Massive Rally

Teva Pharmaceutical Industries is undergoing a strategic transformation, pivoting from generics to innovative biopharmaceuticals. Read more on TEVA here. - Teva Pharmaceutical Industries is undergoing a strategic transformation, pivoting…

markets.businessinsider.com·

Teva (TEVA) Gets a Buy from Piper Sandler

Piper Sandler analyst David Amsellem reiterated a Buy rating on Teva on October 23 and set a price target of $44.00. The company’s shares closed last Friday at ILA12,320.00. According to TipRanks, Amsellem is a 5-star analyst with an…

TradingView·

Gross profit of TAHO Pharmaceuticals Ltd – TWSE:6467

Taho Pharmaceuticals Ltd. engages in the research and development of pharmaceutical products. Its Technology Platform products are the Transepithelial Delivery System, Transdermal DDS, Transmucosal SSD, and Bio-Revie. The firm's Research &…

From the 4Search news index, newest first.

In the news

47mentions in 30 days
9with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 47 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance